Publication | Open Access

Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating α-asarone-based HMG-CoA reductase inhibitors

Molecular PharmacologyMedicinal ChemistryBiochemistryNew ModelMedicineNatural SciencesHypolipidemic AgentsPharmacologyRational Drug DesignPeptide ScienceDrug DevelopmentChemical BiologyMolecular DockingMolecular ModelingSmall MoleculesDrug Discovery